Pfizer Restructuring Reserve decreased by 16.9% to $1.59B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates active restructuring efforts, which may lead to future efficiency gains but also immediate cash outflows.
The estimated liability recorded for costs associated with restructuring activities, such as severance, facility closure...
Commonly seen during periods of strategic transformation or cost-cutting initiatives across the utility industry.
other_restructuring_reserve| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.91B | $1.59B |
| QoQ Change | — | -16.9% |